A phase I trial of AM 831 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 13 Jul 2012
At a glance
- Drugs AM 831 (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- 13 Jul 2012 Status changed from recruiting to discontinued, as reported by ACADIA Pharmaceuticals in its Form 8-K (filed 13 July 2012).
- 09 Nov 2011 Status changed from not yet recruiting to recruiting.
- 07 Nov 2011 The US FDA approved the IND application for this study.